Literature DB >> 6814776

Recent developments in the field of Chagas' disease.

Z Brener.   

Abstract

Chagas' disease is an endemic human trypanosomiasis produced by Trypanosoma cruzi, which is usually transmitted by blood-sucking triatomid bugs. This article reports recent developments in research on Chagas' disease and outlines some of the basic investigations that have immediate practical application or that contribute to our knowledge of the parasite and its relationship with the vertebrate host.Much progress has been made recently in the development of techniques for characterization of T. cruzi strains, e.g., isoenzyme electrophoresis and analysis of kinetoplast DNA, and in research on the biochemistry of the parasite. Studies on membrane components have detected a number of distinct surface glycoproteins which may be important in the interaction between parasite and host cells. New methods of investigating ultrastructural membrane components are also being developed.There is a great need for an animal model in which T. cruzi induces a chronic infection resembling the human disease. Recent work has shown that the rabbit could be a suitable model; monkeys, dogs, and mice are also susceptible to T. cruzi but may not be useful as a model of the disease in man.A number of serological tests are available for the diagnosis of Chagas' disease, e.g., complement-fixation test, immunofluorescence, ELISA haemagglutination, direct agglutination. However, both tests and reagents need to be standardized and active reference centres are necessary to help improve the reliability of the reactions in the different endemic areas.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6814776      PMCID: PMC2536074     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Trypanosoma cruzi: ultrastructural, cytochemical and freeze-fracture studies of protein uptake.

Authors:  W de Souza; T U de Carvalho; M Benchimol; E Chiari
Journal:  Exp Parasitol       Date:  1978-06       Impact factor: 2.011

2.  Isozymic heterogeneity of Trypanosoma cruzi in the first autochthonous patients with Chagas' disease in Amazonian Brazil.

Authors:  M A Miles; A Souza; M Povoa; J J Shaw; R Lainson; P J Toye
Journal:  Nature       Date:  1978-04-27       Impact factor: 49.962

Review 3.  Trypanosoma cruzi: recent biochemical advances.

Authors:  W E Gutteridge
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

4.  Chagas' disease: trends in immunological research and prospects for immunoprophylaxis.

Authors:  A R Teixeira
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

5.  Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages.

Authors:  T L Kipnis; J R David; C A Alper; A Sher; W D da Silva
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

  5 in total
  5 in total

1.  Species-specific monoclonal antibodies for a membrane antigen(s) in all developmental forms of Trypanosoma cruzi.

Authors:  H Tachibana; K Nagakura; Y Kaneda
Journal:  Z Parasitenkd       Date:  1986

2.  Studies on the structure of a phosphoglycoprotein from the parasitic protozoan Trypanosoma cruzi.

Authors:  M A Ferguson; A K Allen; D Snary
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

Review 3.  Therapy and prophylaxis of systemic protozoan infections.

Authors:  W C Van Voorhis
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

4.  Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).

Authors:  E L Malchiodi; M G Chiaramonte; N J Taranto; N W Zwirner; R A Margni
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

5.  Immunofluorescence as an adjunct to the histopathologic diagnosis of Chagas' disease.

Authors:  F W Chandler; J C Watts
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.